✦ LIBER ✦

Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?: Background, Rationale, and Design of a Clinical Trial (Trial of Platelet Prophylaxis) to Assess the Effectiveness of Prophylactic Platelet Transfusions

✍ Scribed by Simon J. Stanworth; Claire Dyer; Louise Choo; Lekha Bakrania; Adrian Copplestone; Charlotte Llewelyn; Derek Norfolk; Gillian Powter; Tim Littlewood; Erica M. Wood; Mike F. Murphy

Book ID: 113933475
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 228 KB
Volume: 24
Category: Article
ISSN: 1532-9496
DOI: 10.1016/j.tmrv.2009.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Background, rationale, and design of a c

Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients

✍ Sherrill J. Slichter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Outlined is the background and rationale for the initiation of a randomized prospective platelet transfusion trial to evaluate the effects of platelet dose on hemostasis and platelet utilization rates. This clinical trial is being performed by the newly established Transfusion Medicine/

Safety and cost effectiveness of a 10×10

Safety and cost effectiveness of a 10×109/L trigger for prophylactic platelet transfusions compared with the traditional 20×109/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia: Wandt H, Frank M, Ehninger G, et al. Blood 91:3601–3606, 1998

✍ Mindy Goldman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 489 KB